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PREVIEW AND COMMENTARY
The Public Health Hazards of Risk
Avoidance Associated With Public Reporting
of Risk-Adjusted Outcomes in Coronary Intervention
Frederic S. Resnic, MD, MSC, Frederick G. P. Welt, MD, MSC
Boston, Massachusetts
Public reporting of risk-adjusted outcomes for percutaneous coronary intervention (PCI) procedures has been
mandated in New York State for more than a decade. During that time there has been a significant decline in
the unadjusted mortality after such procedures. Massachusetts joined New York in 2003 as only the second
state to require case level reporting of every coronary interventional procedure performed. In this review, we ex-
plore the differences in the populations reported by the 2 states and consider possible risks of public reporting
of clinical outcomes after PCI procedures, including the risk of increasing conservatism in the treatment of the
sickest patients. We offer a conceptual framework to understand the potential risk-averse behavior of interven-
tional cardiologists subject to public reporting, and offer several proposals to counteract this potential deleteri-
ous effect of reporting programs. (J Am Coll Cardiol 2009;53:825–30) © 2009 by the American College of
Cardiology Foundation


























iith the recent publication of hospital-specific mortality
utcomes of isolated coronary artery bypass grafting
CABG) and percutaneous coronary intervention (PCI),
assachusetts joined a growing number of states in publicly
eporting risk-adjusted cardiac outcomes (1). Although
here are a number of reasons to enthusiastically support
ublic reporting, there are potential risks that should be
onsidered when evaluating the overall benefits and costs of
uch programs.
The most compelling justification for the public re-
orting of clinical outcomes is the public’s right to know
bout the care that they are likely to receive from
ospitals and physicians they use. Such transparency of
nformation should allow patients to make better in-
ormed decisions about their health care choices. Implicit
n this reasoning is that the public be provided with
ccurate and meaningful data and that access to care
emains unchanged. As will be described in the following
ext, these goals may be more elusive to achieve than
oped by the designers of public reporting programs.
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ccepted November 24, 2008.Beyond the right to know, important potential addi-
ional benefits of public reporting include accelerating the
doption of “best practices” from successful medical
enters, as well as leveraging the scrutiny of performance,
hich typically increases attention to process and quality
mprovement (the Hawthorne effect) (2). As a result of
andated reporting efforts, high quality datasets have
een established and used for critical outcomes research
3–5). Importantly, public reporting provides account-
bility and transparency in regard to quality assurance,
nd thereby enhances trust between patients, regulators,
ayors, and providers (6).
Alongside these clear benefits of public reporting, how-
ver, there are several limitations to current programs and
oncerns regarding unintended consequences of these ef-
orts. Developing optimal data collection instruments and
ssuring adequate data quality from participating centers are
ignificant challenges. In addition, it has been difficult to
evelop risk adjustment methods that adequately account
or the severity of illness in extremely sick patients (7–9).
lthough these risk-adjustment models have demonstrated
xcellent discrimination, calibration, and goodness-of-fit in
he overall patient populations studied, there are concerns
hat these models do not adequately address the patients at
ighest risk (8). Finally, as demonstrated in recent surveys of
nterventional cardiologists, performing physicians may not
ully accept the accuracy of risk adjustment (10), leading to
voidance of higher-risk patients, and providing perverse
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Risks of Public Reporting March 10, 2009:825–30The Massachusetts
Experience With Public
Reporting of PCI Outcomes
The first Massachusetts public
report of PCI risk-adjusted mor-
tality was released in 2005 for
cases performed during 2003; it
demonstrated comparable per-
formance by all Massachusetts
ospitals, as measured by the “Standardized Mortality
ncidence Rate” (11). The statewide unadjusted in-hospital
ortality after PCI was 1.71% (n  12,657 total PCI cases
or the last 9 months of 2003). Results from this report
ndicated that Brigham and Women’s Hospital outcomes
ere within expectations given our case-mix, although
igher-risk patients appeared to experience slightly worse
utcomes compared with statewide averages than the lower-
isk population (neither difference was statistically signifi-
ant). Given the impact of the report on external assessment
f the quality of care at our institution, we undertook a
etailed exploration of the factors associated with mortality
fter PCI. Between January 2003 and December 2005, there
ere 85 in-hospital deaths among 5,050 patients receiving
CI performed at Brigham and Women’s Hospital, with an
nadjusted mortality rate of 1.68%. Although only 2.69% of
atients had presented in cardiogenic shock, these patients
epresented more than 54% of the mortality after PCI, with
uch patients experiencing a 68-fold increase in the risk of
eath as compared with patients not presenting in shock.
As shown in Table 1, 44.7% of patients who died before
ospital discharge had at least 1 severe acute medical condition
resent before the index PCI procedure that was not accounted
or in the data collection instrument used by the state
andated effort (the American College of Cardiology–
ational Cardiovascular Data Registry) (12). Typical exam-
les of such severe acute comorbidities included advanced
alignancy, active infection, acute stroke, perioperative
yocardial infarction after major noncardiac surgery, and
noxic brain injury.
We sought to examine the mortalities further through
etailed review of the clinical record and angiograms in an
ffort to classify the deaths into 1 of 3 categories: 1) no
omplication of the procedure thought to have contributed
o death; 2) complication of procedure possibly related to
haracteristics of Patients Who Died After PCI atrigham and Women’s Ho pital From 2003 to 2005
Table 1 Characteristics of Patients Who Died After PCI atBrigham and Women’s Hospital From 2003 to 2005
Characteristic n % of Deaths
Post-PCI deaths (of 5,050 patients) 85 100
Elective PCI 3 3.5
Pre-procedure cardiogenic shock 46 54.1
STEMI 47 55.3
Simultaneous acute medical event 38 44.7
Noncardiac cause of death 36 42.4
Abbreviations
and Acronyms





myocardial infarctionsCI  percutaneous coronary intervention; STEMI  ST-segment elevation myocardial infarction.atient’s death; and 3) procedural complication materially
ontributing to the patient’s death. Charts and films were
eviewed independently by 2 board-certified interventional
ardiologists blinded to both the identity of the patient and
he performing interventional cardiologist. Determinations
f causality were made based on major neurologic, vascular,
r cardiac complications occurring during the procedure or
uring the hospitalization after the PCI. Examples include
ntracerebral hemorrhage, major vascular complications re-
uiring surgery or leading to hemodynamic instability,
oronary complications including dissection and loss of
essel, or acute or subacute stent thrombosis. Of the 85
eaths, 11 (13%) were categorized as being related to a
omplication of the PCI procedure. An additional 7 (8%)
ere determined to be possibly related to the PCI proce-
ure. The majority of deaths (67 of 85, 79%), however, had
o identifiable complication of the procedure that was
lausibly related to the patient’s death. Implicit in the
ationale for using mortality as an end point of quality is that
eaths are a reasonable surrogate for the overall quality of
he care being provided. These data, however, illustrate that
ess than one-quarter of all deaths were possibly related to
he PCI procedure itself.
Based on this analysis, we sought to improve the perfor-
ance of the standard risk prediction model by adding
vailable pre-procedural data elements including presenta-
ion with neurologic compromise after a presenting cardiac
rrest, history of malignancy, in-hospital onset of acute
oronary syndrome (e.g., after noncardiac surgery), and
resentation to hospital with sepsis. The revised model was
hen tested using a backward selection algorithm on a
oot-strap developed multivariate risk model using our
ingle center PCI experience since 2005. This analysis of
,921 consecutive PCI cases demonstrated that the addition
f the 4 additional covariates modestly improved the dis-
rimination of the model, with an improvement in the area
nder the receiver-operating characteristic curve from 0.919
o 0.937. However, this improvement was not statistically
ignificant, with a pair-wise comparison for improvement in
odel discrimination having a p value of 0.171, despite
dequate power (80%) to detect a difference between the
models.
Although inconclusive, this initial analysis suggests that
here may be additional value to expanding the existing risk
rediction models to include high risk markers available at
ase presentation. In support of this hypothesis is the
vidence from Massachusetts, which has recently begun to
se a composite additional risk factor (“compassionate use
CI”) in the risk adjustment model for Massachusetts PCI
utcomes for 2006. The “compassionate use” variable was
eveloped to identify uniquely high-risk cases that were
aken for PCI when the long-term prognosis of the patient
as unclear to the operator, but when there was a class I
ndication for emergent revascularization. These included
urvivors of cardiac arrest with neurologic impairment in the
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March 10, 2009:825–30 Risks of Public ReportingSTEMI), use of percutaneous ventricular support systems
o facilitate high risk PCI, and survivors of multiple cardiac
rrests en route to the hospital.
Given the complexity and acuity of the patients treated
ith PCI, our analysis would suggest that overall mortality
or a given provider is greatly influenced by the severity of
llness of the patients the operator is willing to take to a
rocedure. We hypothesize that the impact of severity of
llness may be underappreciated by current risk models and
ould significantly affect the estimation of quality of care by
eporting agencies. However, the analysis above is based on
single center’s experience, and may not be representative of
enters that do not perform within the state’s mortality
redication expectation. Nonetheless, it would seem pru-
ent to consider the addition of adjudicated outcomes of
hether a death after PCI was either likely or possibly
elated to the procedure, as unrelated deaths in patients with
lear indications for PCI procedures should not be counted
against” institutions or operators.
omparison With Other
tatewide PCI Reporting Initiatives
ata from the New York PCI registry revealed that the
ortality after PCI has declined from 0.90% in 1997 (13) to
.58% in 2003 (14), a reduction of 36% (p  0.001).
lthough some point to this reduction in mortality as a
uccess, it is important to realize that this improvement in
utcomes can be attributed to many potential factors. It is
ossible that the reduction in mortality is attributable to
mprovements in the quality of care in the state. However,
simultaneous trend toward avoiding performance of PCI
n higher-risk patients may also have contributed to the
bserved reduction in crude mortality in New York State.
vidence supporting this hypothesis includes an observed
imultaneous decline in the proportion of patients present-
ng in cardiogenic shock treated with PCI in New York
rom 1.21% in 1997 to 0.85% in 2003—a 30% decrease
p  0.001) (13,14). During this same time period, there
as been increasing recognition of the importance of emer-
ent revascularization for these patients based on landmark
linical trials and supported by consensus guidelines for the
reatment of STEMI complicated by cardiogenic shock
15,16). In addition, data from the National Registry of
yocardial Infarction suggest increasing incidence of car-
iogenic shock. The most provocative data come from a
ecently published retrospective study of the SHOCK
Should We Emergently Revascularize Occluded Coronar-
es for Cardiogenic Shock) registry comparing the outcomes
f patients from New York and non-New York patients
17). New York State patients presenting with cardiogenic
hock were less likely to receive angiography, PCI, or
ABG. Although there was no significant difference in
ortality for patients undergoing revascularization for
hock between New York and non-New York patients,
n-hospital mortality for New York State sites was 1.5-foldigher for patients not revascularized (p  0.013 for
nteraction of New York site and revascularization). Further
llustrating the difference in treatment patterns, for patients
ndergoing CABG in New York State, the mean time to
ABG was 10-fold higher in New York patients (101.2 h
s. 10.3 h, p  0.001). The authors’ conclusion from these
ata was that public reporting has encouraged a risk-averse
limate in New York State that has real public health
mplications.
Likewise, Massachusetts has released a clinical outcomes
eport covering 2003 to 2005 for PCI (18). As was observed
n New York, the proportion of patients treated with
ardiogenic shock has declined from 2.28% of all PCI cases
n 2003 to 1.29% in 2005, a decline of 43% (Fig. 1). This
ramatic decline was coincident with the first 3 years of
ublic reporting of PCI outcomes in the state. This decline
n the proportion of patients treated with cardiogenic shock
as associated with an observed decline in the overall crude
ortality after PCI in Massachusetts from 1.71% to 1.56%.
This evidence is observational, and one can only infer
causal relationship between the public reporting of
utcomes and the decline in treatment of the sickest
atients in the state. It is important to note that for these
omparisons, we used the broadest possible definition of
hock from the New York registry; shock prevalence was
aken as the sum of patients presenting as hemodynam-
cally “unstable” or in “shock.” This definition is more
nclusive than the American College of Cardiology–
ational Cardiovascular Data Registry definition used in
asssachusetts, and therefore would tend to underesti-
ate the differences between the 2 states in the analysis
hat follows. It is also important to acknowledge that one
annot calculate the true rates of PCI treatment for
ardiogenic shock because clinical hospital admission
Figure 1 Proportion of Patients Undergoing PCI in Massachu-
setts for Cardiogenic Shock, 2003 Through 2005
Decline in proportion of patients undergoing percutaneous coronary interven-
tion (PCI) in Massachusetts for cardiogenic shock, 2003 through 2005. The
proportion of PCI cases that were performed in the setting of cardiogenic
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Risks of Public Reporting March 10, 2009:825–30ates for this diagnosis by year are not publicly available
t present. Therefore, we have chosen to use a surrogate
easure, which is the proportion of patients treated with
CI who presented with cardiogenic shock.
he Risk of “Risk Avoidance Creep”
o help understand how public reporting might influence
linicians to avoid the highest-risk cases, we propose a
ramework of relative risks and benefits and overall clinical
cuity. In Figure 2, the incremental health benefit for a
atient undergoing PCI is plotted along the horizontal axis,
nd the risk of the procedure, here considered to be the
ikelihood of survival to discharge after the procedure, is
lotted along the vertical axis. As shown in Figure 2, the
ramework can be divided into 4 quadrants based on the
rocedural risk (likelihood of survival) and benefit (incre-
ental health benefit to the patient). Shown in green in
igure 2 is the low risk, high benefit (upper right) quadrant,
n which, even in the face of public reporting, there should
e minimal disincentive for physicians to perform the
rocedure. An example of such a case may be an otherwise
ealthy patient presenting with a non–STEMI, in which
ase there is substantial health benefit from PCI, and the
isk of the procedure is quite low. Conversely, there are
ome patients in whom the risk is high and the benefit is
ow, shown in red as the lower left quadrant in Figure 2.
uch a case might include a patient presenting with sepsis
omplicated by a non–STEMI. The upper left and lower
ight quadrants have less certain tradeoffs in terms of risk
nd benefit and are represented in yellow.
Figure 3 illustrates a variety of clinical scenarios with their
utative locations plotted within this relative risk-benefit
ramework. The patient with sepsis and ST-wave changes is
Figure 2 Map of Percutaneous Coronary
Intervention Risk Versus Clinical Benefit
The vertical axis denotes the risk of the procedure represented as the likeli-
hood of survival to hospital discharge. The horizontal axis denotes the patient
benefit represented as the incremental health benefit of having the procedure
performed.lotted in the lower left quadrant (in red). A series ofatients with increasing severity of acute coronary syn-
romes is plotted in the mid-portion of the framework in
ray, with the increasing risk (decreasing likelihood of
urvival) of the procedure noted along with the increasing
ncremental health benefits for the patient. At the extreme,
he patients presenting in cardiogenic shock have the
ighest incremental health benefit gains from PCI, al-
hough their acute risk is also the highest, with observed
ost-procedural mortality rates of 30% to 50%. These cases
re shown in green on the plot. At the other end of the
linical spectrum are patients with minimal or no coronary
rtery disease, who would be at extremely low risk after PCI,
ut who have no clear clinical benefit from the procedure
ither. Inappropriate use of PCI in these low-risk, but “no
enefit,” patients has been observed, as in the series of
atients in California who had minimal coronary disease but
ere nonetheless treated with PCI (19).
Also shown in Figure 3 is the hypothetical migration of
ase-mix away from sickest patients toward lower-risk (and
ower benefit) patients in the face of public reporting of
isk-adjusted outcomes, shown as the dashed red arrow.
ublic reporting of outcomes can be expected to encourage
hysicians to favor procedures in which the patients are at
owest likelihood of death because it has been observed that
ven sophisticated risk adjustment does little to reduce the
endency of physicians to treat lower-risk patients (6).
xacerbating the probable migration of cases from high risk
o low risk are the financial incentives to physicians and
edical centers, which have been shown to drive increased
erformance of procedures when capacity for PCI exists
Figure 3 Potential for “Risk Avoidance Creep”
The map of percutaneous coronary intervention (PCI) risk versus clinical benefit
(see Fig. 2) is shown with illustrative example scenarios. Green ovals indicate
scenarios in which clinical benefit is high, gray ovals indicate intermediate risk,
and red ovals indicate scenarios in which incremental clinical benefit is negligi-
ble. The red dashed arrow indicates the “risk avoidance creep” toward lower-
risk cases in the face of public reporting. CAD  coronary artery disease,
NSTEMI  non–ST-segment elevation myocardial infarction; STEMI  ST-seg-
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March 10, 2009:825–30 Risks of Public Reporting20), and would tend to favor performing an increasing
umber of procedures in lower-risk cases. The tendency to
ecome more conservative in the face of public reporting of
isk-adjusted outcomes is termed “risk avoidance creep,” and
ay partially explain the observed reduction in procedures
or highest-risk patients, despite probable patient benefit.
isk avoidance creep is driven by the concern that public
eporting of risk-adjusted mortality rates may result in either
educed patient referrals or ultimately, a loss of the ability to
rovide the services at all.
trategies for Improvements
o Public Reporting of Outcomes
iven the importance of the public’s right to understand the
uality of care available, public reporting of risk-adjusted
linical outcomes should continue and expand beyond
imply risk-adjusted mortality. However, recognizing the
imitations of public reporting programs and their potential
mpact on physician behavior, the following principles are
roposed in order to maximize the benefits of these pro-
rams while minimizing their potential harm.
. Address the underlying incentives for “case-selection
reep” by improving risk adjustment methods for the
ighest-risk patients and by highlighting centers and
hysicians who undertake high-risk procedures in appro-
riate patients. Currently, outcomes report cards are
ocused almost exclusively on risk-adjusted mortality and
rocedural volumes. If physicians do not completely trust
he risk-adjustment methods used, there is an incentive
o reduce the proportion of the sickest patients treated, in
rder to have a more favorable report card. It is possible
o reduce this incentive by providing additional measures
f quality in the outcomes report, which would discour-
ge “risk avoidance creep.” Reporting the center-specific
roportion of high-risk cases treated, including all pa-
ients who presented with STEMI and, separately, pa-
ients in cardiogenic shock, should help balance the
ncentives. Moreover, additional clinical data elements
hat are likely to confer extreme risk to patients can be
ollected and incorporated into the risk adjustment mod-
ls used. For PCI, these should start with the presence of
ncessant ventricular arrhythmias and the presence of
oma in the setting of an acute coronary syndrome (in
hich neurologic prognosis is unclear at the time of
rgent PCI). Strict and consistent definitions of all data
lements as well as mandatory annual audits of partici-
ating centers are essential for such a system to be
eliable. Consideration of separating out such cases coded
and rigorously audited) as “compassionate use” would
llow physicians to continue to treat the sickest of
atients without fear that such high-risk cases will
dversely affect their report cards due to inadequate risk
djustment.
In addition, emphasis on center-specific public reporting,s opposed to physician-specific reports, could mitigate misk-avoidant behavior by shifting focus from a single person
o what should be encouraged to be a team approach.
ndividual operator outcomes could still be collected and
utliers referred for more thorough review by professional or
tate organizations.
Although states involved in public reporting have
mphasized in-hospital mortality, 30-day or longer mor-
ality may be more appropriate and may avoid the
roblems with accounting for interhospital transfers and
ischarge to nursing homes or hospice. In addition, there
s rationale for nonmortality outcomes, including vascular
r ischemic outcomes, which may be useful as indicators
f technical proficiency and may have statistical advan-
ages due to higher frequency. Finally, investigation of
rocess measures may also help to illuminate differences
n quality. National benchmarks for door to balloon times
hen treating acute myocardial infarction are an example
f such a measure, but also could include discharge on
ppropriate medical therapy.
. Provide adequate resources for assuring high-quality
ata collection and analysis efforts as part of any man-
ated outcomes reporting effort. Collection of universal,
ranular, high-quality datasets is costly in terms of person-
el and information system resources. It must be recognized
hat programs that diligently collect, review, and analyze
etailed internal clinical outcomes data expend significant
esources. For example, Brigham and Women’s Hospital
mploys the equivalent of 2 full-time data coordinators as
ell as a systems administrator for reporting of outcomes of
pproximately 1,800 PCI cases per year. This level of
nfrastructure is required to assure adequate data quality
espite comprehensive point-of-care clinical data collection
ystems and integration of the clinical outcomes database
ystems with the hospital information systems.
. Develop national standards for public reporting of
isk-adjusted clinical outcomes. National consensus
uidelines regarding the domains, scope, methods, and
mplementation of public reporting of clinical outcomes
hould be developed and implemented. Recent recommen-
ations regarding cardiovascular outcomes assessment have
een published (21), but broad adoption and implementa-
ion of such standards is needed. Strategies must be imple-
ented for dataset development and evolution, with the
oal of achieving data element definitions that are opera-
ionally specific, clinically meaningful, and as unambiguous
s possible. In addition, standardized recommendations
egarding optimal statistical methods for risk adjustment
nd reporting should be promulgated (21). In addition,
uidelines as to how and when to investigate outlier perfor-
ances, based on severity and timing of divergence from
xpectations should be developed. A recent report from the
nstitute of Medicine recommended creating a new board
ithin the U.S. Department of Health and Human Services
o coordinate development of standardized performance
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Risks of Public Reporting March 10, 2009:825–30o oversee standards development for public reporting of
isk-adjusted clinical outcomes.
. Develop and report measures of appropriateness to
omplement risk-adjusted outcomes in public reporting
rograms. In addition to standard reporting of risk-adjusted
utcomes and procedure volumes, significant attention should
e devoted to studying procedure appropriateness and access to
are. Assurance that “risk avoidance creep” does not occur, and
hat inappropriate low-risk patients are not being treated
nnecessarily would likely require surveillance of a sample of
epresentative angiograms from all practitioners. Where con-
erns are raised, a more thorough examination of practice
atterns could be instituted. Equally important in the measures
f appropriateness would be institution of measures to ascertain
he proportion of high-risk patients who are not receiving
enerally indicated procedures. Specifically, collecting clinical
ata on all myocardial infarction patients treated at an institu-
ion, rather than only on those who undergo PCI, could
rovide insight into whether a center is evolving toward a more
onservative approach, which may be at odds with its mission
or comprehensive care of all patients presenting to that
nstitution.
onclusions
ur analysis of data from the Massachusetts experience with
ublic reporting raises serious concerns about the unintended
mpact on clinical care. Clinical outcomes report cards serve a
aluable public health purpose and should continue to expand as
he public demands accountability from the health care system.
owever, this analysis raises concern over whether overall mor-
ality is a reliable guide to quality. As practicing interventional
ardiologists, we are concerned that we occasionally consider the
mpact of potential adverse events on our hospital’s outcomes
hen evaluating the risks and benefits of a procedure for a
articularly ill patient. However well-intentioned the practice of
ublic reporting may be, the consequences appear to have had the
pposite effect.With the thoughtful adoption of principles such as
hose outlined above, the significant benefits of public reporting of
isk-adjusted outcomes may be achieved while minimizing the
otentially deleterious effects of reducing physician willingness to
erform procedures on patients who would significantly benefit
rom them.
eprint requests and correspondence: Dr. Frederic S. Resnic,
ardiovascular Division, Brigham and Women’s Hospital, 75
rancis Street, Boston, Massachusetts 02115. E-mail: fresnic@
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